OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KDP$28.4058

Keurig Dr Pepper Inc

Non-Alcoholic BeveragesVerified

Keurig Dr Pepper maintains a capital structure with a debt-to-equity ratio of 0.63, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.51, suggesting limited short-term liquidity. Free cash flow stands at $230 million, but cash and equivalents are only $438 million, which is significantly lower than the long-term debt of $15.6 billion. Profitability metrics show a return on equity of 2.08% and a return on assets of 0.98%, both of which are below the industry median for non-alcoholic beverage producers. The company's operating margin is 21.95% (calculated from operating income of $861 million on revenue of $3.92 billion), which is in line with the sector average but leaves room for improvement in cost management. Geographically, Keurig Dr Pepper's revenue is heavily concentrated in the United States, with no material international operations disclosed. The company's product portfolio is split between its Keurig and Dr Pepper Snapple brands, with the Keurig division representing a significant portion of revenue. No material segment-specific financials are disclosed in the latest financial snapshot. Looking ahead, the company is projected to see a modest growth in revenue, with analysts forecasting a mean price target of $33.50, representing a 18% upside from the current market price of $28.40. The mean recommendation of 2.33 suggests a cautiously optimistic outlook, with 3 strong-buy ratings and 6 buy ratings among 18 total analyst opinions. Risk factors include a medium liquidity risk due to the current ratio of 0.51 and a negative net cash position after subtracting total debt. The company has a low dilution risk, with no significant dilution potential reported in the latest financial data. However, the high debt-to-equity ratio and limited free cash flow could constrain flexibility in capital allocation. Recent events include the release of the latest financial data, which shows a stable revenue of $3.92 billion and a net income of $515 million. No major regulatory or operational events were disclosed in the latest filings, and the company has not issued any new shares in the recent period.

30-day price · KDP(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyKeurig Dr Pepper Inc
TickerKDP.O
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryNon-Alcoholic Beverages
AI analysis

Business. Keurig Dr Pepper Inc is a leading manufacturer and distributor of non-alcoholic beverages, including ready-to-drink coffee, tea, juice, and carbonated soft drinks, primarily in the United States.

Classification. Keurig Dr Pepper is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Non-Alcoholic Beverages industry, with a confidence level of 0.92.

Keurig Dr Pepper maintains a capital structure with a debt-to-equity ratio of 0.63, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.51, suggesting limited short-term liquidity. Free cash flow stands at $230 million, but cash and equivalents are only $438 million, which is significantly lower than the long-term debt of $15.6 billion. Profitability metrics show a return on equity of 2.08% and a return on assets of 0.98%, both of which are below the industry median for non-alcoholic beverage producers. The company's operating margin is 21.95% (calculated from operating income of $861 million on revenue of $3.92 billion), which is in line with the sector average but leaves room for improvement in cost management. Geographically, Keurig Dr Pepper's revenue is heavily concentrated in the United States, with no material international operations disclosed. The company's product portfolio is split between its Keurig and Dr Pepper Snapple brands, with the Keurig division representing a significant portion of revenue. No material segment-specific financials are disclosed in the latest financial snapshot. Looking ahead, the company is projected to see a modest growth in revenue, with analysts forecasting a mean price target of $33.50, representing a 18% upside from the current market price of $28.40. The mean recommendation of 2.33 suggests a cautiously optimistic outlook, with 3 strong-buy ratings and 6 buy ratings among 18 total analyst opinions. Risk factors include a medium liquidity risk due to the current ratio of 0.51 and a negative net cash position after subtracting total debt. The company has a low dilution risk, with no significant dilution potential reported in the latest financial data. However, the high debt-to-equity ratio and limited free cash flow could constrain flexibility in capital allocation. Recent events include the release of the latest financial data, which shows a stable revenue of $3.92 billion and a net income of $515 million. No major regulatory or operational events were disclosed in the latest filings, and the company has not issued any new shares in the recent period.
Key takeaways
  • Keurig Dr Pepper has a moderate debt load and limited short-term liquidity.
  • Profitability metrics are below the industry median, indicating potential for improvement.
  • The company's revenue is heavily concentrated in the United States.
  • Analysts are cautiously optimistic, with a mean price target of $33.50.
  • The company faces medium liquidity risk and a negative net cash position.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$3.92B
Gross profit$2.17B
Operating income$861.0M
Net income$515.0M
R&D
SG&A
D&A
SBC
Operating cash flow$742.0M
CapEx-$322.0M
Free cash flow$230.0M
Total assets$52.34B
Total liabilities$27.63B
Total equity$24.72B
Cash & equivalents$438.0M
Long-term debt$15.62B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$12.68B$2.77B$2.15B$1.29B
FY-3$14.06B$2.38B$1.44B$517.0M
FY-2$14.81B$3.19B$2.18B$1.10B
FY-1$15.35B$2.59B$1.44B$180.0M
FY0$16.60B$3.58B$2.08B$919.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$50.60B$24.97B$567.0M
FY-3$51.84B$25.13B$535.0M
FY-2$52.13B$25.68B$267.0M
FY-1$53.43B$24.24B$510.0M
FY0$55.46B$25.52B$1.03B
PeriodOCFCapExFCFSBC
FY-4$2.87B-$455.0M$1.29B
FY-3$2.84B-$379.0M$517.0M
FY-2$1.33B-$481.0M$1.10B
FY-1$2.22B-$622.0M$180.0M
FY0$1.99B-$503.0M$919.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$3.92B$861.0M$515.0M$230.0M
FQ-6$3.89B$902.0M$616.0M$335.0M
FQ-5$4.07B$61.0M-$144.0M-$485.0M
FQ-4$3.63B$801.0M$517.0M$211.0M
FQ-3$4.16B$898.0M$547.0M$271.0M
FQ-2$4.31B$995.0M$662.0M$390.0M
FQ-1$4.50B$881.0M$353.0M$47.0M
FQ0$3.98B$756.0M$270.0M-$9.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$52.34B$24.72B$438.0M
FQ-6$52.72B$24.97B$552.0M
FQ-5$53.43B$24.24B$510.0M
FQ-4$53.70B$24.45B$653.0M
FQ-3$54.37B$24.98B$509.0M
FQ-2$54.60B$25.32B$516.0M
FQ-1$55.46B$25.52B$1.03B
FQ0$73.14B$29.68B$898.0M
PeriodOCFCapExFCFSBC
FQ-7$742.0M-$322.0M$230.0M
FQ-6$1.37B-$447.0M$335.0M
FQ-5$2.22B-$622.0M-$485.0M
FQ-4$209.0M-$134.0M$211.0M
FQ-3$640.0M-$242.0M$271.0M
FQ-2$1.28B-$354.0M$390.0M
FQ-1$1.99B-$503.0M$47.0M
FQ0$281.0M-$118.0M-$9.0M
Valuation
Market price$28.40
Market cap$38.64B
Enterprise value$53.82B
P/E75.0
Reported non-GAAP P/E
EV/Revenue13.7
EV/Op income62.5
EV/OCF72.5
P/B1.6
P/Tangible book1.6
Tangible book$24.72B
Net cash-$15.18B
Current ratio0.5
Debt/Equity0.6
ROA1.0%
ROE2.1%
Cash conversion1.4%
CapEx/Revenue-8.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Beverages · cohort 230 companies
MetricKDPActivity
Op margin22.0%7.8% medp25 1.7% · p75 17.7%top quartile
Net margin13.1%6.0% medp25 0.6% · p75 13.7%above median
Gross margin55.4%39.8% medp25 29.2% · p75 50.5%top quartile
CapEx / revenue-8.2%-5.9% medp25 -12.7% · p75 -3.1%below median
Debt / equity63.0%23.3% medp25 1.2% · p75 56.7%top quartile
Observations
IR observations
Mean price target33.50 USD
Median price target32.00 USD
High price target42.00 USD
Low price target28.00 USD
Mean recommendation2.33 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count6.00
Hold count9.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2.28 USD
Last actual EPS2.05 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 06:44 UTC#d0a5ee7e
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 07:39 UTCJob: 7cf65333